Credit Suisse’s American Renal Associates Holdings, Inc ARA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-15,557
Closed -$95K 4295
2019
Q1
$95K Buy
15,557
+3,441
+28% +$39.9K ﹤0.01% 3852
2018
Q4
$140K Buy
12,116
+1,583
+15% +$27K ﹤0.01% 3732
2018
Q3
$229K Sell
10,533
-1,685
-14% -$31.9K ﹤0.01% 3618
2018
Q2
$192K Sell
12,218
-19,300
-61% -$303K ﹤0.01% 3774
2018
Q1
$594K Buy
31,518
+19,730
+167% +$389K ﹤0.01% 3274
2017
Q4
$205K Buy
+11,788
New +$163K ﹤0.01% 3742
2016
Q4
Sell
-22,367
Closed -$408K 4294
2016
Q3
$408K Buy
+22,367
New +$504K ﹤0.01% 3526

Other funds holding ARA

Credit Suisse's ARA Position: Q2 2019 in Review

Credit Suisse sold out of American Renal Associates Holdings, Inc (ARA) in Q2 2019, closing a stake of 15,557 shares — an estimated $95K sold.

Credit Suisse first reported a position in ARA in Q3 2016 and held it in 7 quarters. The position peaked at $594K in Q1 2018. 67 funds tracked by Wall St. Rank hold ARA as of Q2 2019.

  • Credit Suisse reported no remaining American Renal Associates Holdings, Inc position as of Q2 2019 after selling out during the quarter.
  • Credit Suisse sold 15,557 American Renal Associates Holdings, Inc shares in Q2 2019, an estimated $95K.
  • Credit Suisse first reported a position in American Renal Associates Holdings, Inc in Q3 2016 and held it in 7 quarters.
  • Credit Suisse's American Renal Associates Holdings, Inc position peaked at $594K in Q1 2018.
  • 67 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q2 2019.

Based on Credit Suisse's 13F filing for Q2 2019, filed 14 Aug 2019.